In vivo assessment of drug efficacy against Plasmodium falciparum malaria: Duration of follow-up

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 11, 2004, Pages 4271-4280

  Stepniewska, Kasia ^a,j   Taylor, Walter R J ^c   Mayxay, Mayfong ^d   Price, Ric ^a,j   Smithuis, Frank ^e   Guthmann, Jean Paul ^f   Barnes, Karen ^g   Myint, Hla Yin ^a   Adjuik, Martin ^c   Olliaro, Piero ^c   Pukrittayakamee, Sasithon ^a   Looareesuwan, Sornchai ^a   Hien, Tran Tinh ⁱ   Farrar, Jeremy ^h   Nosten, François ^a,b,j   Day, Nicholas P J ^a,j   White, Nicholas J ^a,j  

^a MAHIDOL UNIVERSITY   (Thailand)

^b SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d MAHOSOT HOSPITAL   (Laos)

^e MÉDECINS SANS FRONTIÈRES   (Switzerland)

^f EPICENTRE   (France)

^g UNIVERSITY OF CAPE TOWN   (South Africa)

^h OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

ⁱ UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^j CHURCHILL HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; CLINDAMYCIN; DIHYDROARTEMISININ; DOXYCYCLINE; FANSIDAR; HALOFANTRINE; MEFLOQUINE; PIPERAQUINE; QUININE; RIFAMPICIN; TETRACYCLINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG CLASSIFICATION; DRUG EFFICACY; DRUG HALF LIFE; FOLLOW UP; GENOTYPE; HUMAN; IN VIVO STUDY; INOCULATION; MALARIA FALCIPARUM; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REINFECTION; TREATMENT FAILURE; TREATMENT OUTCOME; VALIDATION PROCESS;

ALGORITHMS; ANIMALS; ANTIMALARIALS; DRUG RESISTANCE; ENDPOINT DETERMINATION; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TREATMENT FAILURE;

EID: 7244219957     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.11.4271-4280.2004     Document Type: Article

References (74)

1. Adjuik, M., P. Agnamey, A. Babiker, S. Borrman, P. Brasseur, M. Cisse, F. Cobelens, S. Diallo, J. F. Faucher, P. Garner, S. Gikunda, P. G. Kremsner, S. Krishna, B. Lell, M. Loolpapit, P. B. Matsiegui, M. A. Missinou, J. Mwanza, F. Ntoumi, P. Olliaro, P. Osimbo, P. Rezbach, E. Some, and W. R. Taylor. 2002. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomized, multicentre trial. Lancet 359:1365-1372.
2. Adjuik, M., A. Babiker, P. Garner, P. Olliaro, W. Taylor, N. White, et al. 2004. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363:9-17.
3. Bloland, P. B., and M. Ettling. 1999. Making malaria-treatment policy in the face of drug resistance. Ann. Trop. Med. Parasitol. 93:5-23.
4. Brockman, A., R. E. Paul, T. J. Andersen, I. Hackford, L. Phaiphun, S. Looareesuwan, F. Nosten, and K. P. Day. 1999. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. Am. J. Trop. Med. Hyg. 60:14-21.
5. Checchi, F., R. Durand, S. Balkan, B. T. Vonhm, J. Z. Kollie, P. Biberson, E. Baron, J. Le Bras, and J. P. Guthmann. 2002. High Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine in Harper, Liberia: results in vivo and analysis of point mutations. Trans. R. Soc. Trop. Med. Hyg. 96:664-669.
6. Checchi, F., S. Balkan, B. T. Vonhm, M. Massaquoi, P. Biberson, P. Eldin de Pecoulas, P. Brasseur, and J. P. Guthmann. 2002. Efficacy of amodiaquine for uncomplicated Plasmodium falciparum malaria in Harper, Liberia. Trans. R. Soc. Trop. Med. Hyg. 96:670-673.
7. Covell, G., G. R. Coatney, J. W. Field, and J. Singh. 1955. Chemotherapy of malaria. W. H. O. monograph series 27. World Health Organization, Geneva, Switzerland.
8. Djimde, A., O. K. Dourabo, R. W. Steketee, and C. V. Plowe. 2001. Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Lancet 358:890-891.
9. Djimde, A., O. K. Doumbo, J. F. Cortese, K. Kayentao, S. Doumbo, Y. Diourte, A. Dicko, X. Z. Su, T. Nomura, D. A. Fidock, T. E. Wellems, C. V. Plowe, and D. Coulibaly. 2001. A molecular marker for chloroquine-resistant falciparum malaria. N. Engl. J. Med. 344:257-263.
10. Djimde, A. A., O. K. Doumbo, O. Traore, A. B. Guindo, K. Kayentao, Y. Diourte, S. Niare-Doumbo, D. Coulibaly, A. K. Kone, Y. Cissoko, M. Tekete, B. Fofana, A. Dicko, D. A. Diallo, T. E. Wellems, D. Kwiatkowski, and C. V. Plowe. 2003. Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 69:558-563.
11. Dorsey, G., Njama, M. R. Kamya, A. Cattamanchi, D. Kyabayinze, S. G. Staedke, A. Gasasira, and P. J. Rosenthal. 2002. Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomized trial. Lancet 360:2031-2038.
12. Driessen, G. J., S. van Kerkhoven, B. J. Schouwenberg, G. Bonsu, and J. P. Verhave. 2002. Sulphadoxine/pyrimethamine: an appropriate first-line alternative for the treatment of uncomplicated falciparum malaria in Ghanaian children under 5 years of age. Trop. Med. Int. Health 7:577-583.
13. Farnert, A., A. P. Arez, H. A. Babiker, H. P. Beck, A. Benito, A. Bjorkman, M. C. Brace, D. J. Conway, K. P. Day, L. Henning, O. Mercereau-Puijalon, L. C. Ranford-Cartwright, J. M. Rubio, G. Snounou, D. Walliker, J. Zwetyenga, and V. E. de Rosario. 2001. Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. Trans. R. Soc. Trop. Med. Hyg. 95:225-232.
14. Fontanet, A. L., B. D. Johnston, A. M. Walker, Y. Bergqvist, U. Hellgren, and W. Rooney. 1994. Falciparum malaria in eastern Thailand: a randomised trial of the efficacy of a single dose of mefloquine. Bull. W. H. O. 72:73-81.
15. Guthmann, J. P., S. Kasparian, R. Phetsouvanh, N. Nathan, M. Garcia, S. Phonipida, A. Brockman, M. Gastellu, and D. Legros. 2002. The efficacy of chloroquine for the treatment of acute, uncomplicated, Plasmodium falciparum malaria in Laos. Ann. Trop. Med. Parasitol. 96:553-557.
16. Harinasuta, T., D. Bunnag, and W. H. Wernsdorfer. 1983. A phase II clinical trial of mefloquine in patients with chloroquine-resistant falciparum malaria in Thailand. Bull. W. H. O. 61:299-305.
17. Hien, T. T., P. P. Mai, C. Dolecek, P. Phuong, N. T. Dung, N. T. Truong, N. Thanh, L. H. Thai, D. T. H. An, N. T. H. Quyen, N. J. White, and J. J. Farrar. 2004. Dihydroartemisinin-piperaquine against multidrug resistant falciparum malaria in Viet Nam: randomized clinical trial. Lancet 363:18-22.
18. Hung, L. N., P. J. de Vries, T. D. Le, L. Bich, P. L. Ho, N. H. Tran, et al. 1997. Single dose artemisinin-mefloquine versus mefloquine alone for uncomplicated falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 91:191-194.
19. Kofoed, P. E., F. Lopez, P. Johansson, A. Sandstrom, K. Hedegaard, P. Aaby, and L. Rombo. 2002. Treatment of children with Plasmodium falciparum malaria with chloroquine in Guinea-Bissau. Am. J. Trop. Med. Hyg. 67:28-31.
20. Korenromp, E. L., B. G. Williams, E. Gouws, C. Dye, and R. W. Snow. 2003. Measurement of trends in childhood malaria mortality in Africa: an assessment f progress toward targets based on verbal autopsy. Lancet Infect. Dis. 3:349-358.
21. Legros, D., K. Johnson, P. Houpikian, M. Makanga, J. K. Kabakyenga, A. O. Talisuna, and W. R. Taylor. 2002. Clinical efficacy of chloroquine or sulfadoxine-pyrimethamine in children under five from south-western Uganda with uncomplicated falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 96:199-201.
22. Luxemburger, C., F. ter Kuile, F. Nosten, G. Dolan, J. H. Bradol, L. Phaipun, T. Chongsuphajaisiddhi, and N. J. White. 1994. Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 88:213-217.
23. Luxemburger, C., F. Nosten, D. Rainiond, T. Chongsuphajaisiddhi, and N. J. White. 1995. Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria. Am. J. Trop. Med. Hyg. 53:522-525.
24. Luxemburger, C., R. N. Price, F. Nosten, F. ter Kuile, T. Chongsuphajaisiddhi, and N. J. White. 1996. Mefloquine in infants and young children. Ann. Trop. Paediatr. 16:281-286.
25. Marsh, K. 1998. Malaria disaster in Africa. Lancet 352:1965-1967.
26. Mayxay, M., K. Chotivanich, S. Pukrittayakamee, P. Newton, S. Looareesuwan, and N. J. White. 2001. Contribution of humoral immunity to the therapeutic response in falciparum malaria. Am. J. Trop. Med. Hyg. 65:918-923.
27. Mayxay, M., P. N. Newton, M. Khanthavong, P. Tiengkham, R. Phetsouvanh, S. Phompida, A. Brockman, and N. J. White. 2003. Chloroquine versus sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum malaria in Savannakhet province, Lao People's Democratic Republic: an assessment of national antimalarial drug recommendations. Clin. Infect. Dis. 37:1021-1028.
28. Mayxay, M., R. Phetsouvanh, S. Phompida, P. N. Newton, M. Khanthavong, B. Vannachone, A. Brockman, and N. J. White. 2003. A randomised comparison of oral chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in Laos. Trans. R. Soc. Trop. Med. Hyg. 97:343-344.
29. McGready, R., T. Cho, L. Hkirijaroen, J. Simpson, T. Chongsuphajaisiddhi, N. J. White, and F. Nosten. 1998. Quinine and mefloquine in the treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy. Ann. Trop. Med. Parasitol. 92:643-653.
30. McGready, R., A. Brockman, T. Cho, D. Cho, M. van Vugt, C. Luxemburger, T. Chongsuphajaisiddhi, N. J. White, and F. Nosten. 2000. Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multi-drug resistant falciparum malaria in pregnancy. Trans. R. Soc. Trop. Med. Hyg. 94:689-693.
31. McGready, R., T. Cho T. N. K. Keo, K. L. Thwai, L. Villegas, S. Looareesuwan, N. J. White, and F. Nosten. 2001. Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum. Clin. Infect. Dis. 33:2009-2016.
32. McGready, R., T. Cho, Samuel, L. Villegas, A. Brockman, M. van Vugf, S. Looareesuwan, N. J. White, and F. Nosten. 2001. Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy. Trans. R. Soc. Trop. Med. Hyg. 95:651-656.
33. McGready, R., K. L. Thwai, T. Cho, Samuel, S. Looareesuwan, N. J. White, and F. Nosten. 2002. The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy. Trans. R. Soc. Trop, Med. Hyg. 96:180-184.
34. Myint, H. Y., P. Tipmanee, F. Nosten, S. Pukrittayakamee, N. P. J. Day, S. Looareesuwan, and N. J. White. 2004. A systematic overview of published antimalarial drug trials. Trans. R. Soc. Trop. Med. Hyg. 98:73-81.
35. Nosten, F., F. ter Kuile, T. Chongsuphajaisiddhi, C. Luxemburger, H. K. Webster, M. Edstein, L. Phaipun, K. L. Thew, and N. J. White. 1991. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet 337:1140-1143.
36. Nosten, F., C. Luxemburger, F. O. ter Kuile, C. Woodrow, J. Pa Eh, T. Chongsuphajaisiddhi, and N. J. White. 1994. Treatment of multi-drug resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. J. Infect. Dis. 170:971-977.
37. Nosten, F., and E. Ashley. 2004. The detection and treatment of Plasmodium falciparum malaria: time for change. J. Postgrad. Med. 50:35-39.
38. Pillai, D. R., A. C. Labbe, V. Vanisaveth, B. Hongvangthong, S. Pomphida, S. Inkathone, K. Zhong, and K. C. Kain. 2001. Plasmodium falciparum malaria in Laos: chloroquine treatment outcome and predictive value of molecular markers. J. Infect. Dis. 183:789-795.
39. Plowe, C. 2003. Monitoring antimalarial drug resistance: making the most of the tools at hand. J. Exp. Biol. 206:3745-3752.
40. Plowe, C. V., J. G. Kublin, F. K. Dzinjalamala, D. S. Kamwendo, R. A. Mukadam, P. Chimpeni, M. E. Molyneux, and T. E. Taylor. 2004. Sustained clinical efficacy of sulphadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study. Br. Med. J. 328:545-548.
41. Price, R. N., F. Nosten, C. Luxemburger, A. Kham, A. Brockman, T. Chongsuphajaisiddhi, and N. J. White. 1995. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 89:523-527.
42. Price, R. N., F. Nosten, C. Luxemburger, M. van Vugt, L. Phaipun, T. Chongsuphajaisiddhi, and N. J. White. 1997. Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 91:574-577. [Erratum: 92:122, 1998.]
43. Price, R. N., C. Luxemburger, M. van Vugt, F. Nosten, A. Kham, J. Simpson, S. Looareesuwan, T. Chongsuphajaisiddhi, and N. J. White. 1998. Artesunate and mefloquine in the treatment of uncomplicated multi-drug resistant hyperparasitaemic falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 92:207-211.
44. Price, R. N., M. van Vugt, F. Nosten, C. Luxemburger, A. Brockman, L. Phaipun, T. Chongsuphajaisiddhi, and N. J. White. 1998. Artesunate versus artemether for the treatment of recrudescent multi-drug resistant falciparum malaria. Am. J. Trop. Med. Hyg. 59:883-888.
45. Price, R. N., F. Nosten, C. Luxemburger, L. Phaipun, F. O. ter Kuile, M. van Vugt, T. Chongsuphajaisiddhi, and N. J. White. 1999. Risk factors for gametocyte carriage in uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg. 60:1019-1023.
46. Price, R. N., C. Cassar, A. Brockman, M. Duraisingh, M. van Vugt, N. J. White, F. Nosten, and S. Krishna. 1999. The pfmdrI gene is associated with a multidrug resistance phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob. Agents Chemother, 43:2943-2949.
47. Price, R. N., J. Simpson, F. Nosten, C. Luxemburger, L. Hkirjaroen, F. O. ter Kuile, T. Chongsuphajaisiddhi, and N. J. White. 2001. Factors contributing to anemia in uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg. 65:614-622.
48. Pukrittayakamee, S., A. Chantra, S. Vanijanonta, R. Clemens, S. Looareesuwan, and N. J. White. 2000. Therapeutic responses to quinine and clindamycin in multidrug-resistant falciparum malaria. Antimicrob. Agents Chemother. 44:2395-2398.
49. Pukrittayakamee, S., S. Prakongpan, S. Wanwimolruk, R. Clemens, S. Looareesuwan, and N. J. White. 2003. Adverse effect of rifampin on quinine efficacy in uncomplicated falciparum malaria. Antimicrob. Agents Chemother. 47:1509-1513.
50. Pukrittayakamee, S., S. Wanwimolruk, K. Stepniewska, A. Jantra, S. Huyakorn, S. Looareesuwan, and N. J. White. 2003. Quinine pharmacokinetic pharmacodynamic relationships in uncomplicated falciparum malaria. Antimicrob. Agents Chemother. 47:3458-3563.
51. Schellenberg, D., E. Kahigwa, C. Drakeley, A. Malende, A., J. Wigayi, C. Msokame, J. J. Aponte, M. Tanner, H. Mshinda, C. Menendez, and P. L. Alonso. 2002. The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 67:17-23.
52. Simpson, J. A., E. R. Watkins, R. N. Price, L. Aarons, D. E. Kyl, and N. J. White. 2000. Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance. Antimicrob. Agents Chemother. 44:3414-3424.
53. Smithuis, F. M., J. B. van Woensel, E. Nordlander, W. S. Vantha, and F. O. ter Kuile. 1993. Comparison of two mefloquine regimens for the treatment of Plasmodium falciparum malaria on the northeastern Thai-Cambodian border. Antimicrob. Agents Chemother. 37:1977-1981.
54. Smithuis, F., I. van der Broek, I. Katterman, M. K. Kyaw, A. Brockman, S. Lwin, and N. J. White. 2004. Optimising operational use of artesunatemefloquine; a randomised comparison of four treatment regimens. Trans. R. Soc. Trop. Med. Hyg. 98:182-192.
55. Sowunmi, A., F. A. Fehintola, A. A. Adedeji, A. G. Falade, C. O. Falade, O. O. Akinyinka, and A. M. Oduola. 2000. Comparative efficacy of chloroquine plus chlorpheniramine alone and in a sequential combination with sulfadoxine-pyrimethamine, for the treatment of acute, uncomplicated, falciparum malaria in children, Ann. Trop. Med. Parasitol. 94:209-217.
56. Sowunmi, A., A. I. Ayede, A. G. Falade, V. N. Ndikum, C. O. Sowunmi, A. A. Adedeji, C. O. Falade, T. C. Happi, and A. M. Oduola. 2001. Randomized comparison of chloroquine and amodiaquine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children. Ann. Trop. Med. Parasitol. 95:549-558.
57. ter Kuile, F., F. Nosten, M. Thieren, C. Luxemburger, M. D. Edstein, T. Chongsuphajaisiddhi, L. Phaipun, H. K. Webster, and N. J. White. 1992. High dose mefloquine in the treatment of multidrug resistant falciparum malaria. J. Infect. Dis. 166:1393-1400.
58. ter Kuile, F. O., G. Dolan, F. Nosten, M. D. Edstein, C. Luxemburger, L. Phaipun, T. Chongsuphajaisiddhi, H. K. Webster, and N. J. White. 1993. Halofantrine versus mefloquine in the treatment of multi-drug resistant falciparum malaria. Lancet 341:1044-1049.
59. Trape, J. F., G. Pison, M. P. Preziosi, C. Enel, A. Desgrees du Lou, V. Delaunay, B. Samb, E. Lagarde, J. F. Molez, and F. Simondon. 1998. Impact of chloroquine resistance on malaria mortality. C. R. Acad. Sci. III, Sci. Vie 321:689-697.
60. Vanijanonta, S., A. Chantra, N. Phophak, D. Chindanond, R. Clemens, and S. Pukrittayakamee. 1996. Therapeutic effects of chloroquine in combination with quinine in uncomplicated falciparum malaria. Ann. Trop. Med. Parasitol. 90:269-275.
61. van Vugt, M., A. Brockman, B. Gemperli, C. Luxemburger, I. Gathman, C. Royce, T. Slight, S. Looareesuwan, N. J. White, and F. Nosten. 1998. Randomised comparison of artemether-benflumetol and artesunate-mefloquine in the treatment of multi-drug resistant falciparum malaria. Antimicrob. Agents Chemother. 42:135-139.
62. van Vugt, M., P. Wilairatana, B. Gemperli, I. Gathmann, L. Phaipun, A. Brockman, C. Luxemburger, N. J. White, F. Nosten, and S. Looareesuwan. 1999. Efficacy of six doses or artemether-benflumetol in the treatment of multi-drug resistant falciparum malaria. Am. J. Trop. Med. Hyg. 60:936-942.
63. van Vugt, M., S. Looareesuwan, P. Wilairatana, R. McGready, L. Villegas, I. Gathmann, R. Mull, A. Brockman, N. J. White, and F. Nosten. 2000. Artemether-lumefantrine for the treatment of multidrug resistant falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 94:545-548.
64. van Vugt, M., E. Leonardi, L. Phaipun, T. Slight, K. L. Thway, R. McGready, A. Brockman, L. Villegas, S. Looareesuwan, N. J. White, and F. Nosten. 2002. Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil. Clin. Infect. Dis. 35:1498-1504.
65. Viriyakosol, S., N. Siripoon, C. Petcharapirat, P. Petcharapirat, W. Jarrar, S. Thaithong, K. N. Brown, and G. Snounou. 1995. Genotyping of Plasmodium falciparum isolates by the polymerase chain reaction and potential uses in epidemiological studies. Bull. W. H. O. 73:85-95.
66. von Seidlein, L., P. Milligan, M. Finder, K. Bojang, C. Anyalebechi, R. Gosling, R. Coleman, J. I. Dde, A. Sadiq, M. Duraisingh, D. Warhurst, A. Alloueche, G. Targett, K. McAdam, B. Greenwood, G. Walraven, P. Olliaro, and T. Doherty. 2000. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double blind, randomised, controlled trial. Lancet 355:352-357.
67. White, N. J. 1997. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob. Agents Chemother. 41:1413-1422.
68. White, N. J. 1999. Antimalarial drug resistance and mortality in falciparum malaria. Trop. Med. Int. Health 4:469-470.
69. White, N. J. 2002. The assessment of antimalarial drug efficacy. Trends Parasitol. 18:458-464.
70. World Health Organization. 1973. Chemotherapy of malaria and resistance to antimalarials. Report of a W. H. O. Scientific Group. W.H.O. Tech. Rep. Ser. 529:30-35.
71. World Health Organization. 1986. The chemotherapy of malaria. W. H. O. monograph series 27. World Health Organization, Geneva, Switzerland.
72. World Health Organization. 1996. Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. W.H.O./MAL/96.1077. World Health Organization, Geneva, Switzerland.
73. World Health Organization. 2002. Monitoring antimalarial drug resistance. Report of a W.H.O. consultation, W.H.O./CDS/CSR/EPH/2002.17. World Health Organization, Geneva, Switzerland.
74. Yorke, W., and J. W. S. MacFie. 1924. Observations on malaria made during treatment of general paralysis. Trans. R. Soc. Trop. Med. Hyg. 18:33-39.